Skip to main content

Headlines

CSL Reports Negative Outcome In Phase 3 Trial Of CSL112 In Heart Attack Treatment
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Oragenics Preparing For Phase II Trial In Treatment Of Concussion - Quick Facts
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Merck's Keytruda Reduces Risk Of Death By 38% In Adjuvant RCC Therapy In Phase 3 Trial
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Applied Therapeutics Announces Mixed Results From Phase 3 Trial Of AT-001 In Diabetic Cardiomyopathy
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Argenx : Phase 3 Study Of Efgartigimod SC In Pemphigus Fails To Meet Primary & Secondary Endpoints
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Vertex Announces Positive Results From Phase 2 Study Of VX-548 In Diabetic Peripheral Neuropathy
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Novartis: Phase III Study Shows Superiority Of Iptacopan In Patients With C3 Glomerulopathy
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
MorphoSys : Pelabresib Improves All Four Hallmarks Of Myelofibrosis In Phase 3 Study
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
AstraZeneca : Phase III Trial Data Show Danicopan Sustained Clinical Improvements In PNH
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Novartis : Phase III Trial Results Show Sustained Efficacy & Long-term Safety Of Fabhalta In PNH
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Anixa Biosciences Announces Positive Data From Phase 1 Study Of Breast Cancer Vaccine; Stock Up
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Carisma Therapeutics Gets FDA Clearance To Start Phase 1 Study Of CT-0525 In Solid Tumors
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
MorphoSys : Phase 3 Study Of Pelabresib Combination In Myelofibrosis Meets Primary Endpoint
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Bayer Stops Phase III Study Of Asundexian In Atrial Fibrillation Due To Lack Of Efficacy
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Karuna Announces Positive Results From Phase 1b BP Monitoring Trial Of KarXT In Schizophrenia
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets